CA Patent

CA2792392A1 — The use of amisulpride as an anti-emetic

Assigned to Acacia Pharma Ltd · Expires 2011-09-15 · 15y expired

What this patent protects

Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilise a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.

USPTO Abstract

Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilise a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.

Drugs covered by this patent

Patent Metadata

Patent number
CA2792392A1
Jurisdiction
CA
Classification
—
Expires
2011-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Acacia Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.